These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21566961)

  • 1. Mutational activation of k-ras oncogene in human breast-tumors.
    Koffa M; Malamoumitsi V; Agnantis N; Spandidos D
    Int J Oncol; 1994 Mar; 4(3):573-6. PubMed ID: 21566961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
    Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
    Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified mismatch polymerase chain reaction-restriction fragment length polymorphism detected mutations in codon 12 and 13 of exon 2 of K-
    Faleel FD; Zoysa MI; Lokuhetti MD; Gunawardena YI; Chandrasekharan VN; Dassanayake RS
    J Cancer Res Ther; 2016; 12(4):1272-1277. PubMed ID: 28169239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and spectrum of K-RAS codons 12 and 13 mutations in colorectal adenocarcinomas from Taiwan.
    Wu CM; Tang R; Wang JY; Changchien CR; Hsieh LL
    Cancer Genet Cytogenet; 2005 Apr; 158(1):55-60. PubMed ID: 15771905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T; Reynolds S; Maronpot R; Anderson M
    Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ha-ras oncogene (codon 12) mutation in thyroid carcinogenesis: analysis of 60 benign and malignant thyroid tumors.
    Bouras M; Parvaz P; Berger N; Paulin C; Revol A
    Ann Biol Clin (Paris); 1995; 53(10-11):549-55. PubMed ID: 8787281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of codon 61 point mutations of the K-ras gene in lung and colorectal cancers by enriched PCR.
    Toyooka S; Tsukuda K; Ouchida M; Tanino M; Inaki Y; Kobayashi K; Yano M; Soh J; Kobatake T; Shimizu N; Shimizu K
    Oncol Rep; 2003; 10(5):1455-9. PubMed ID: 12883723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras oncogene mutations in childhood brain tumors.
    Maltzman TH; Mueller BA; Schroeder J; Rutledge JC; Patterson K; Preston-Martin S; Faustman EM
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):239-43. PubMed ID: 9107428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR.
    Nollau P; Moser C; Weinland G; Wagener C
    Int J Cancer; 1996 May; 66(3):332-6. PubMed ID: 8621253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K-ras activation in premalignant and malignant epithelial lesions of the human uterus.
    Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM
    Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A PCR-RFLP method for the detection of activated H-ras oncogene with a point mutation at codon 12 and 61.
    Hong SJ; Lee T; Park YS; Lee KO; Chung BH; Lee SH
    Yonsei Med J; 1996 Dec; 37(6):371-9. PubMed ID: 9048488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the ras genes in malignant and premalignant colorectal tumors.
    Glarakis IS; Savva S; Spandidos DA
    Oncol Rep; 1998; 5(6):1451-4. PubMed ID: 9769386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
    Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
    Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors.
    Capella G; Cronauer-Mitra S; Pienado MA; Perucho M
    Environ Health Perspect; 1991 Jun; 93():125-31. PubMed ID: 1685441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of ras gene mutations in early gastric carcinomas.
    Craanen ME; Blok P; Top B; Boerrigter L; Dekker W; Offerhaus GJ; Tytgat GN; Rodenhuis S
    Gut; 1995 Dec; 37(6):758-62. PubMed ID: 8537044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Not infrequent K-ras mutations in depressed-type early colorectal carcinomas larger than 10 mm.
    Kazama S; Ajioka Y; Watanabe H; Watanabe T; Nagawa H
    Jpn J Cancer Res; 2002 Feb; 93(2):178-83. PubMed ID: 11856481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ras gene mutations in human endometrial carcinoma.
    Varras MN; Koffa M; Koumantakis E; Ergazaki M; Protopapa E; Michalas S; Spandidos DA
    Oncology; 1996; 53(6):505-10. PubMed ID: 8960147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of K-ras oncogene activation in human lung cancer and its possible clinical application].
    Zhang G; Sun Y; Wang M
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Oct; 18(5):282-4, 317. PubMed ID: 8762479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.